Predialysis systolic BP variability and outcomes in hemodialysis patients
- PMID: 24385593
- PMCID: PMC3968504
- DOI: 10.1681/ASN.2013060667
Predialysis systolic BP variability and outcomes in hemodialysis patients
Abstract
BP variability (BPV) is an important predictor of outcomes in the general population, but its association with clinical outcomes in hemodialysis patients is not clear. We identified 11,291 patients starting dialysis in 2003-2008 and followed them through December 31, 2008 (median=22 months). Predialysis systolic BPV was assessed over monthly intervals. Outcomes included factors associated with BPV, mortality (all-cause and cardiovascular), and first cardiovascular event (cardiovascular death or hospitalization). Patients' mean age was 62 years, 55% of patients were men, and 58% of patients were white. Modifiable factors associated with higher BPV included obesity, higher calcium-phosphate product levels, and lower hemoglobin concentration; factors associated with lower BPV included greater fluid removal, achievement of prescribed dry weight during dialysis, higher hemoglobin concentration, and antihypertensive regimens without β-blockers or renin-angiotensin system blocking agents. In total, 3200 deaths occurred, including 1592 cardiovascular deaths. After adjustment for demographics, comorbidities, and clinical factors, higher predialysis BPV was associated with increased risk of all-cause mortality (hazard ratio [HR], 1.18; 95% confidence interval [95% CI] per 1 SD increase in BPV, 1.13 to 1.22), cardiovascular mortality (HR, 1.18; 95% CI, 1.12 to 1.24), and first cardiovascular event (HR, 1.11; 95% CI, 1.07 to 1.15). Results were similar when BPV was categorized in tertiles and patients were stratified by baseline systolic BP. In summary, predialysis systolic BPV is an important, potentially modifiable risk factor for death and cardiovascular outcomes in incident hemodialysis patients. Studies of BP management in dialysis patients should focus on both absolute BP and BPV.
Figures
Comment in
-
Blood pressure variability and dialysis: variability may not always be the spice of life.J Am Soc Nephrol. 2014 Apr;25(4):650-3. doi: 10.1681/ASN.2013111237. Epub 2014 Jan 2. J Am Soc Nephrol. 2014. PMID: 24385594 Free PMC article. No abstract available.
Similar articles
-
Long-term predialysis blood pressure variability and outcomes in hemodialysis patients.J Clin Hypertens (Greenwich). 2022 Feb;24(2):148-155. doi: 10.1111/jch.14398. Epub 2022 Jan 28. J Clin Hypertens (Greenwich). 2022. PMID: 35089648 Free PMC article.
-
The association of interdialytic blood pressure variability with cardiovascular events and all-cause mortality in haemodialysis patients.Nephrol Dial Transplant. 2019 Mar 1;34(3):515-523. doi: 10.1093/ndt/gfy247. Nephrol Dial Transplant. 2019. PMID: 30184172
-
Antihypertensive medications and risk of death and hospitalizations in US hemodialysis patients: Evidence from a cohort study to inform hypertension treatment practices.Medicine (Baltimore). 2017 Feb;96(5):e5924. doi: 10.1097/MD.0000000000005924. Medicine (Baltimore). 2017. PMID: 28151871 Free PMC article.
-
Hemodialysis-associated hypertension: pathophysiology and therapy.Am J Kidney Dis. 2002 Feb;39(2):227-44. doi: 10.1053/ajkd.2002.30542. Am J Kidney Dis. 2002. PMID: 11840363 Review.
-
Intensive Hemodialysis, Blood Pressure, and Antihypertensive Medication Use.Am J Kidney Dis. 2016 Nov;68(5S1):S15-S23. doi: 10.1053/j.ajkd.2016.05.026. Am J Kidney Dis. 2016. PMID: 27772639 Review.
Cited by
-
Interdialytic home systolic blood pressure variability increases all-cause mortality in hemodialysis patients.Clin Cardiol. 2024 Apr;47(4):e24259. doi: 10.1002/clc.24259. Clin Cardiol. 2024. PMID: 38549547 Free PMC article.
-
Seasonal variation in predialysis systolic blood pressure and cardiovascular events in patients on maintenance hemodialysis.Hypertens Res. 2023 Sep;46(9):2192-2202. doi: 10.1038/s41440-023-01364-1. Epub 2023 Jul 7. Hypertens Res. 2023. PMID: 37420091
-
Intra-dialytic blood pressure variability is a greater predictor of cardiovascular events in hemodialysis patients.BMC Nephrol. 2023 Apr 26;24(1):113. doi: 10.1186/s12882-023-03162-w. BMC Nephrol. 2023. PMID: 37101121 Free PMC article.
-
Intercorrelated variability in blood and hemodynamic biomarkers reveals physiological network in hemodialysis patients.Sci Rep. 2023 Jan 30;13(1):1660. doi: 10.1038/s41598-023-28345-1. Sci Rep. 2023. PMID: 36717578 Free PMC article.
-
Impact of fluid overload on blood pressure variability in patients on peritoneal dialysis.Ren Fail. 2022 Dec;44(1):2066-2072. doi: 10.1080/0886022X.2022.2148535. Ren Fail. 2022. PMID: 36415108 Free PMC article.
References
-
- Agarwal R, Nissenson AR, Batlle D, Coyne DW, Trout JR, Warnock DG: Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med 115: 291–297, 2003 - PubMed
-
- Levin NW, Kotanko P, Eckardt KU, Kasiske BL, Chazot C, Cheung AK, Redon J, Wheeler DC, Zoccali C, London GM: Blood pressure in chronic kidney disease stage 5D-report from a Kidney Disease: Improving Global Outcomes controversies conference. Kidney Int 77: 273–284, 2010 - PubMed
-
- Weir MR: Debate from the 2012 ASH Annual Scientific Sessions: Should blood pressure be reduced in hemodialysis patients? Con position. J Am Soc Hypertens 6: 443–447, 2012 - PubMed
-
- Agarwal RL: Debate from the 2012 ASH Annual Scientific Sessions: Should blood pressure be reduced in hemodialysis patients? Pro position. J Am Soc Hypertens 6: 439–442, 2012 - PubMed
-
- Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Greenland S, Kopple JD: Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: The 58th annual fall conference and scientific sessions. Hypertension 45: 811–817, 2005 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
